» Authors » Brian Vickery

Brian Vickery

Explore the profile of Brian Vickery including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 435
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos A, Riggioni C, Agache I, Akdis C, Akdis M, Alvarez-Perea A, et al.
Allergy . 2024 Oct; 80(1):14-36. PMID: 39473345
This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management of IgE-mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and...
2.
Patrawala M, Lee G, Vickery B
J Food Allergy . 2024 Jul; 2(1):124-127. PMID: 39022144
Historically, the role of the health-care provider in medical practice has been primarily paternalistic by offering information, compassion, and decisive views with regard to medical decisions. This approach would exclude...
3.
Anagnostou A, Vickery B
J Allergy Clin Immunol Pract . 2023 May; 11(8):2330-2334. PMID: 37236350
Background: Food oral immunotherapy (OIT) is an active form of treatment for food allergies. Although research in this area has been ongoing for many years, the first US Food and...
4.
Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner P, Shinder S, et al.
World Allergy Organ J . 2023 Mar; 16(3):100753. PMID: 36910595
Background: While several scoring systems for the severity of anaphylactic reactions have been developed, there is a lack of consensus on definition and categorisation of severity of food allergy disease...
5.
Herbert L, Marchisotto M, Vickery B
Curr Treat Options Allergy . 2021 Feb; 8(1):9-20. PMID: 33520599
Purpose: Food allergy management places a daily psychosocial burden on patients and their caregivers. New food allergy treatments may positively impact their lives, but also introduce new stressors. The purpose...
6.
Patrawala M, Shih J, Lee G, Vickery B
Curr Allergy Asthma Rep . 2020 Apr; 20(5):14. PMID: 32314071
Purpose Of The Review: Peanut oral immunotherapy (OIT) is one of the most studied experimental therapies for food allergy. With the recently FDA-approved peanut product, Palforzia, the goal of this...
7.
Wheatley L, Wood R, Nadeau K, Liu A, Zoratti E, Bacharier L, et al.
J Allergy Clin Immunol . 2019 Feb; 143(5):1711-1726. PMID: 30731123
The Agency for Healthcare Research and Quality and the National Institute of Allergy and Infectious Diseases organized a workshop to develop trial concepts that could improve the use and effectiveness...
8.
Bute J, Broome S, Marcus J, Mikulcik S, Vickery B
Allergy . 2018 Apr; 73(7):1551-1553. PMID: 29624719
No abstract available.
9.
Bird J, Groetch M, Allen K, Bock S, Leonard S, Nowak-Wegrzyn A, et al.
J Allergy Clin Immunol Pract . 2016 Nov; 5(2):301-311.e1. PMID: 27838326
Results from the Learning Early About Peanut trial and its follow-up study suggest that early peanut introduction in the diets of high-risk infants may prevent the development of peanut allergy....
10.
Varshney P, Jones S, Scurlock A, Perry T, Kemper A, Steele P, et al.
J Allergy Clin Immunol . 2011 Mar; 127(3):654-60. PMID: 21377034
Background: Open-label oral immunotherapy (OIT) protocols have been used to treat small numbers of patients with peanut allergy. Peanut OIT has not been evaluated in double-blind, placebo-controlled trials. Objective: To...